Wolfgang Dörr was born in Förbau/Bavaria, Germany, in 1959. He finished his university training in veterinary medicine in 1985, the doctoral promotion (DVM), both at the Ludwig-Maximilians-University in Munich, in 1988, and his habilitation in medical sciences at the Technological University Dresden in 1997. His career in the field of radiobiology started in 1986 at the GSF Research Center (now Helmholtz Center Munich) in Munich/Neuherberg, Germany. Since 1995 he is senior scientist and head of the Normal Tissue Radiobiology Group at the Department of Radiotherapy and Radiation Oncology at the Technological University in Dresden, with an associate professorship from 2002. After being deputy head for 15 years, he became head of the Section of Radiobiology in 2010. From 2003-2012, he was deputy director of the Experimental Animal Facility of the Medical Faculty in Dresden, as well as the animal protection liaison officer of the TUD and the Helmholtz Research Center Dresden-Rossendorf. In 2001, he was appointed as lecturer at the Faculty of Veterinary Medicine of the University of Leipzig, Germany. Also since 2003, he is member of various sections of the German Radiation Protection Commission. From 2007-2012, he was appointed a visiting professorship for radiobiology by the Medical University of Vienna. In July 2012, he took a position at the Department for Radiation Oncology of Medical University of Vienna/AKH.
His primary research focus are normal tissue effects of (therapeutic) radiation exposure: pathogenesis, regulatory processes and their modification, quantification and documentation, and prophylactic and management approaches. A variety of normal tissues, including oral mucosa, skin, intestine, heart, lung, and urinary bladder are characterised with regard to their pathophysiological response to radio- and radiochemotherapy. For this, experimental in-vitro and animal models are being exploited. In parallel, he also studies parameters and mechanisms of tumour effects of radiation and their selective modification. Moreover, he investigates the risk of radiation-induced second cancers. Analyses of clinical data of normal tissue complications of radio(chemo)therapy and participation in clinical studies and the organization of the Dresden mouth care programme completes the translational aspect of his research.
He is author or co-author of more than 320 journal publications and presented more than 480 contributions in conferences and symposia. Moreover he contributed essentially to 8 books as editor or author, including ”Kinische Strahlenbiologie, Elvesier, 2006” and “Basic Clinical Radiobiology, Hodder Arnold 2009”, and is Editor-in-Chief of the “Newsletter of European Research in Radiological Sciences (http://www.euradnews.org)”. Wolfgang Dörr is member of the editorial boards of various journals, including "Radiotherapy and Oncology", "Radiation and Environmental Biophysics" and "Strahlentherapie und Onkologie". Moreover he is reviewer for several national and international scientific journals and funding organisations and he is also member in various scientific committees. He is co-organiser of the regular course of clinical radiation biology in Germany and Austria, and teacher at the ESTRO teaching course on Basic Clinical Radiobiology. He organised several national and international workshops, symposia and conferences on radiobiology in radiation oncology.
Wolfgang Dörr was and is council member (1996-2004 and since 2009)/vice president (2001-2001)/president (2003-2004) of the European Society for Radiation Research, council member (1998-2000)/president elect (2000-2002)/president (2002-2006) of the German Society for Radiation Biology, council member (1999-2004)/chairman (2004-2006) of the European Late Effects Project Group, member of the Radiobiology Committee of the European Society for Radiotherapy and Oncology (2000-2011), and council member of the German Society for Radiation Oncology (2009-2011).
Wolfgang Dörr received the Hans-Langendorff-Preis of the Association of the German Radiation Protection Physicians and the Hanns Langendorff Foundation (Bregenz, 1998), the Honorary Membership of the European Late Effects Project Group (2006) and the Honorary Membership of the Österreichische Gesellschaft für Radioonkologie, Radiobiologie und Medizinische Radiophysik (2011).